240
Participants
Start Date
February 11, 2022
Primary Completion Date
July 30, 2022
Study Completion Date
July 30, 2022
P1211216
Flavor variant P1211216 of a 1.5% nicotine ENDS product
P1213416
Flavor variant P1213416 of a 1.5% nicotine ENDS product
P1213716
Flavor variant P1213716 of a 1.5% nicotine ENDS product
P1213616
Flavor variant P1213616 of a 1.5% nicotine ENDS product
P1213816
Flavor variant P1213816 of a 1.5% nicotine ENDS product
P1211916
Flavor variant P1211916 of a 1.5% nicotine ENDS product
P1210016
Flavor variant P1210016 of a 1.5% nicotine ENDS product
P1211217
Flavor variant P1211217 of a 2.4% nicotine ENDS product
P1213417
Flavor variant P1213417 of a 2.4% nicotine ENDS product
P1211222
Flavor variant P1211222 of a 5% nicotine ENDS product
P1213422
Flavor variant P1213422 of a 5% nicotine ENDS product
P1213722
Flavor variant P1213722 of a 5% nicotine ENDS product
P1213622
Flavor variant P1213622 of a 5% nicotine ENDS product
P1213822
Flavor variant P1213822 of a 5% nicotine ENDS product
P1211922
Flavor variant P1211922 of a 5% nicotine ENDS product
P1210022
Flavor variant P1210022 of a 5% nicotine ENDS product
High Point Clinical Trials Center, High Point
Accellacare Hickory, Hickory
Clinical Research Atlanta, Stockbridge
AMR Lexington, Lexington
RAI Services Company
INDUSTRY